Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes
Authors
Keywords
Breast cancer, Diabetes, Metformin
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 137, Issue 3, Pages 807-816
Publisher
Springer Nature
Online
2013-01-05
DOI
10.1007/s10549-012-2404-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin and breast cancer risk: a meta-analysis and critical literature review
- (2012) Nananda F. Col et al. BREAST CANCER RESEARCH AND TREATMENT
- Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival
- (2012) C. J. Currie et al. DIABETES CARE
- Diabetes, Metformin, and Breast Cancer in Postmenopausal Women
- (2012) Rowan T. Chlebowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer
- (2011) X. He et al. ANNALS OF ONCOLOGY
- Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
- (2011) Sirwan Hadad et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer
- (2011) Soley Bayraktar et al. CANCER
- The impact of type 2 diabetes mellitus on cancer-specific survival
- (2011) Xiangdong Liu et al. CANCER
- The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells
- (2011) Alejandro Vazquez-Martin et al. CELL CYCLE
- Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo
- (2011) Vladimir N. Anisimov et al. CELL CYCLE
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
- (2011) Goodarz Danaei et al. LANCET
- Type 2 diabetes mellitus and prognosis in early stage breast cancer women
- (2011) Muhammet Ali Kaplan et al. MEDICAL ONCOLOGY
- Association between Body-Mass Index and Risk of Death in More Than 1 Million Asians
- (2011) Wei Zheng et al. NEW ENGLAND JOURNAL OF MEDICINE
- The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth
- (2010) Yin-Hsun Feng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Linking diabetes and cancer: a consensus on complexity
- (2010) Andrew Renehan et al. LANCET
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case–control study
- (2009) C. Agnoli et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
- (2008) R. Stuart-Harris et al. BREAST
- The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase
- (2008) M. Zakikhani et al. Cancer Prevention Research
- Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus
- (2008) Bethany B. Barone JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
- (2008) Giuseppe Viale et al. JOURNAL OF CLINICAL ONCOLOGY
- The Impact of Transgenic IGF-IR Overexpression on Mammary Development and Tumorigenesis
- (2008) Robert A. Jones et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started